论文部分内容阅读
Aim: Bone morphogenetic protein type Ⅱ receptor (BMPR-Ⅱ) mutations are responsible for over 70% of cases of heritable pulmonary arterial hypertension (PAH) and up to 15%-40% of sporadic idiopathic disease.Loss of BMP signalling promotes pulmonary vascular remodelling via modulation of pulmonary artery smooth muscle cell (PASMC) migration, differentiation and proliferation.